Short-Term Intraocular Pressure Elevations after Combined Phacoemulsification and Implantation of Two Trabecular Micro-Bypass Stents: Prednisolone versus Loteprednol

Table 2

IOP and NGM reductions reported in previous studies and current study.

Study	Number	Topical steroid	Follow-up (mo)	Mean IOP reduction (mmHg) ± SD	Mean NGM reduction ± SD
Spiegel et al. [13]	58	NA	12	4.4 ± 4.54	1.2 ± 0.7
Fea [3]	12	NA	15	3.2 ± 3.0	2.0 ± 0.9
Samuelson et al. [2]	106	Prednisolone	12	1.5 ± 3.0	1.4 ± 0.8
Arriola-Villalobos et al. [4]	19	Dexamethasone	53.68 ± 9.26	3.16 ± 3.9	0.47 ± 0.96
Current study	96	—	3	2.50 ± 5.80	1.38 ± 1.43
	38	Prednisolone		1.93 ± 6.58	1.5 ± 1.23
	58	Loteprednol		3.49 ± 5.23	1.31 ± 0.56

SD: standard deviation.